Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
Li & Fung Ltd
Watchlist
Li & Fung Continues to Be Undervalued Despite the Share Price Spike
Equity Bottom-Up
293 Views
30 Aug 2017 00:39
No-moat Li & Fung Ltd (494 HK)'s earnings beat was not all due to the speed initiatives and improvement in the consumer sector in the U.S. that...
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 59-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
Japan
Event-Driven
Sell / Short Ideas
Equity Bottom-Up
Asia Event-Driven
India
Unpaywalled Insights
Philippines
Asia ECM
Trending Insights
More »
Sichuan Kelun Biotech (6990 HK): Price Surge & Global Index Inclusion
NIFTY50 Index Rebalance Preview: Forecast Changes, Impact, Positioning
Anthem Biosciences IPO: Lists Today; Index Inclusion Timing
Reece (REH AU): Positioning Increases as Global Index Deletion Nears
Crime Scene Investigation: How Seven&I (3382-JP) Murdered the ACT (ATD-CA) Deal
Top Unpaywalled Insights
More »
HK Connect SOUTHBOUND Flows (To 18 July 2025); Volumes Strong, Net Buying Decent, Meituan Hot
Curator's Cut: Japan Insurers Vs Banks, the State of the Chinese EV Sector and Asian Ports in Focus
[IO Technicals 2025/29] Near Term Bullish Trend to Persist
Veon's (Nasdaq: VEON) Subsidiary Kyivstar Eyes Nasdaq Listing
Reimagining Venture Capital Through Impact Investing | Chris Maher on Disability Innovation
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Li & Fung's FVE Decreased to HKD 3.64 With Negative Moat Trend as We Transfer Coverage
06 Dec 2017
Li & Fung Chart Turn Around Points
09 Oct 2017
It's Been Time to Revisit Li & Fung in Recent Weeks
04 Oct 2017
Li & Fung Continues to Be Undervalued Despite the Share Price Spike
30 Aug 2017
Given an Innovate or Die Bent, Li & Fung Deserves the Benefit of the Doubt; Shares a Bit Undervalued
03 Apr 2017
Li & Fung Is One of the Casualties of the Choi Soon Shil Scandal
01 Nov 2016
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.54.9
x